Serum biomarkers identify patients who will develop inflammatory bowel diseases up to 5 years before diagnosis
The honest answer is that it depends on the indication, and the timeline varies enough between tissue types that a single number is misleading
My guess still remains that there's been an error in the process somewhere and it's 'crept out'
Research Interest in BPC-157 + TB-500 Scientific literature has explored BPC-157 and TB-500 across numerous laboratory models involving peptide biology, extracellular matrix research, protein interactions, molecular signaling pathways, cellular communication, and analytical peptide chemistry
Hence, validation of the patients experiences is important
A Holistic Approach to Understanding: A thorough understanding of AUD involves exploring multiple dimensions